COLL Collegium Pharmaceutical, Inc.
$25.21
Collegium Pharmaceutical, Inc. (COLL) Earnings News
Earnings press releases, previews and reviews for Collegium Pharmaceutical, Inc. (COLL), newest first. Our most recent is review: Collegium Beats on ADHD Strength, but Pain Erosion and Heavier Spending Keep Earnings Shrinking.
Thursday
November 5, 2026
9:50 AM ET
Collegium Beats on ADHD Strength, but Pain Erosion and Heavier Spending Keep Earnings Shrinking
Earnings Whispers · Review
Thursday
November 5, 2026
7:30 AM ET
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
Wednesday
October 28, 2026
1:37 PM ET
Collegium Needs Jornay and Astaris to Outrun a Fading Nucynta Franchise
Earnings Whispers · Preview
Thursday
October 22, 2026
8:00 AM ET
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
Thursday
August 6, 2026
7:30 AM ET
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Thursday
July 23, 2026
8:00 AM ET
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026